What question did this study set out to answer?

To comprehensively evaluate the comparative efficacy and safety of pharmacological, psychosocial, and alternative treatment options for children and adolescents with clinically diagnosed ADHD.

March 25, 2024PEDIATRICS

Treatments for ADHD in Children and Adolescents: A Systematic Review

View Full Paper

Ask AI

Bookmark

Authors

BPBradley S. PetersonUniversity of Geneva JTJoey W. TrampushQueens College, CUNY MMMargaret MaglioneUniversity of Southern California

Discussion

Member takes

Implication

Systematic review reveals medications offer the strongest symptom improvements in pediatric ADHD, highlighting the need to balance clinical efficacy against potential adverse events.

Key Points

To comprehensively evaluate the comparative efficacy and safety of pharmacological, psychosocial, and alternative treatment options for children and adolescents with clinically diagnosed ADHD.
Searched 12 databases from 1980 to June 2023 for controlled evaluations in children and adolescents with clinically diagnosed ADHD, screening records with machine-learning assistance.
Synthesized data across 312 studies reported in 540 publications, pooling outcome data using random-effects models according to Evidence-based Practice Center standards.
Medications yielded the most robust evidence base for reducing core ADHD symptoms and disruptive behaviors, though they were consistently linked to adverse events.
Nonpharmacological interventions—including psychosocial strategies, exercise, neurofeedback, neurostimulation, and school-based support—improved symptoms, but combining medication with youth-directed psychosocial care did not systematically outperform monotherapy.
Head-to-head evidence comparing distinct treatments remained sparse, and indirect analyses revealed few systematic differences between stimulant and nonstimulant medications.

Cite This Study

Peterson et al. (2024) studied this question.

synapsesocial.com/papers/6a024fc22f52e40b1a9f4856 https://doi.org/10.1542/peds.2024-065787

View Full Paper

Ask AI

Bookmark

March 25, 2024PEDIATRICS

Treatments for ADHD in Children and Adolescents: A Systematic Review

View Full Paper

Ask AI

Bookmark

Authors

BPBradley S. PetersonUniversity of Geneva JTJoey W. TrampushQueens College, CUNY MMMargaret MaglioneUniversity of Southern California

Discussion

Member takes

Implication

Systematic review reveals medications offer the strongest symptom improvements in pediatric ADHD, highlighting the need to balance clinical efficacy against potential adverse events.

Key Points

To comprehensively evaluate the comparative efficacy and safety of pharmacological, psychosocial, and alternative treatment options for children and adolescents with clinically diagnosed ADHD.
Searched 12 databases from 1980 to June 2023 for controlled evaluations in children and adolescents with clinically diagnosed ADHD, screening records with machine-learning assistance.
Synthesized data across 312 studies reported in 540 publications, pooling outcome data using random-effects models according to Evidence-based Practice Center standards.
Medications yielded the most robust evidence base for reducing core ADHD symptoms and disruptive behaviors, though they were consistently linked to adverse events.
Nonpharmacological interventions—including psychosocial strategies, exercise, neurofeedback, neurostimulation, and school-based support—improved symptoms, but combining medication with youth-directed psychosocial care did not systematically outperform monotherapy.
Head-to-head evidence comparing distinct treatments remained sparse, and indirect analyses revealed few systematic differences between stimulant and nonstimulant medications.

Cite This Study

Peterson et al. (2024) studied this question.

synapsesocial.com/papers/6a024fc22f52e40b1a9f4856 https://doi.org/10.1542/peds.2024-065787

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark